Inicio>>Signaling Pathways>> Apoptosis>> Other Apoptosis>>Euscaphic acid

Euscaphic acid

Catalog No.GC38392

El Ácido euscÁfico, un inhibidor de la ADN polimerasa, es un triterpeno de la raÍz de R. alceaefolius Poir. Euscaphic inhibe la ADN polimerasa α de ternera (pol α) y la ADN polimerasa β de rata (pol β) con valores IC50 de 61 y 108 μM. El Ácido euscÁfico induce la apoptosis.

Products are for research use only. Not for human use. We do not sell to patients.

Euscaphic acid Chemical Structure

Cas No.: 53155-25-2

Tamaño Precio Disponibilidad Cantidad
1mg
117,00 $
Disponible
5mg
342,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Euscaphic acid, a DNA polymerase inhibitor, is a triterpene from the root of the R. alceaefolius Poir. Euscaphic inhibits calf DNA polymerase α (pol α) and rat DNA polymerase β (pol β) with IC50 values of 61 and 108 μM[1]. Euscaphic acid induces apoptosis[2].

Euscaphic acid induces apoptosis and cell cycle arrest in NPC cells by suppression of the PI3K/AKT/mTOR signaling pathway[2].

[1]. Murakami C, et al. Novel anti-inflammatory compounds from Rubus sieboldii, triterpenoids, are inhibitors of mammalian DNA polymerases. Biochim Biophys Acta. 2002 Apr 29;1596(2):193-200. [2]. Dai W, et al. Euscaphic acid inhibits proliferation and promotes apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway. Am J Transl Res. 2019 Apr 15;11(4):2090-2098.

Reseñas

Review for Euscaphic acid

Average Rating: 5 ★★★★★ (Based on Reviews and 1 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Euscaphic acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.